Dr. Sabreen Faqihi, MD

Dr. Faqihi practices at California Dermatology Institute in Los Angeles, California.

Dr. Faqihi's NPI, 1588126148, was assigned on April 3, 2019. Dr. Faqihi graduated from Central Michigan University College of Medicine in 2019. Dr. Faqihi holds California license A184674.

Dr. Faqihi's primary practice is California Dermatology Institute, at 1701 E Cesar E Chavez Ave, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (805) 222-5803.

Dr. Faqihi's primary practice is California Dermatology Institute in Los Angeles, California. The medical group on file is California Dermatology Institute. Dmand AI also links Dr. Faqihi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Faqihi practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Faqihi's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Faqihi's licenses on file in 2 states: California and Illinois.

Dmand AI lists benign or precancerous skin growths, contact dermatitis, psoriasis, scalp rash, skin cyst and skin discoloration among the conditions Dr. Faqihi treats.

CMS data shows 439 Medicare services from Dr. Faqihi across 9 procedure codes in 2024, for 115 Medicare patients. Medicare paid $27,516 for them. Every service was in an office.

CMS counts 115 Medicare patients who saw Dr. Faqihi in 2024. The largest group is 65 to 74, with 69 patients. 73% of them have high blood pressure, and 72% have high cholesterol. 89% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Faqihi's median patient age at 51, with 59% women.

In 2024, Dr. Faqihi wrote 1,273 Medicare Part D claims for 350 patients. 92% of them were for generic drugs. CMS names the drug for 1,158 of them, across 24 drugs with 11 or more claims each, at $201,885 in total drug cost. In 2023, CMS named 327 claims across 12 drugs.

Dr. Faqihi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Faqihi as offering telehealth. CMS counts 330 procedures of removal of skin lesions by Dr. Faqihi, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Faqihi. Dr. Faqihi's most frequent co-authors are Lee Alkureishi, MBCHB and Anders Mellgren, MD.

CMS Open Payments shows 14 general payments to Dr. Faqihi from 5 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $258.

Dr. Faqihi graduated from Central Michigan University College of Medicine in 2019. Dr. Faqihi is a member of AMA, Medical Dermatology Society, Pacific Dermatologic Association and Women’s Dermatologic Society.

Dr. Faqihi is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Molina. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.